SERVICES

• Recombinant Protein or Antibody Production • Protein Expression Systems > Bacterial Expression Systems(E. coli / Bacillus) > Yeast Expression Systems(P pastoris / S cerevisiae) > Baculovirus-insect Cell Expression Systems > Mammalian Expression Systems(CHO / 293) • PEGylation Services • Stable Cell Line Construction for Protein Expression • Process Development • cGMP Manufacturing • QC and QA • Bacterial Manufacturing • Bacteria Expression • Yeast Expression • Mammalian Cell Expression • Insect Cell Expression • Animal-free Expression • Cell-free protein expression • Large-scale Protein Production • PEGylation Services • Basic Protein Characterization • Protein Labeling • Stable Cell Line Construction for Protein Expression • Protein Mutagenesis • Protein Interaction Analysis Services > Yeast Two-Hybrid Screening > Membrane-based Yeast Two-Hybrid Screening > Co-Immunoprecipitation (Co-IP) > Surface plasmon resonance (SPR) Service > Pull Down Assay > Bio-layer Interferometry (BLI) Service > CLIP-Seq Service > Protein Binding Site Mapping • Yeast Two-Hybrid Screening • Membrane-based Yeast Two-Hybrid Screening • Co-Immunoprecipitation (Co-IP) • Surface plasmon resonance (SPR) Service • Pull Down Assay • Protein Mutant Library Construction • Enzyme Target & Activator & Inhibitor Screening Service • GPCR Screening Service • Ion Channel Screening Service • Bio-layer Interferometry (BLI) Service • Electrophoretic Mobility Shift Assay (EMSA) Service • Transcription Factor Analysis > Electrophoretic Mobility Shift Assay (EMSA) Service > Chromatin Immunoprecipitation (ChIP) Assay Service > DNase I Footprinting Assay Service • Transporter Screening Service • Chromatin Immunoprecipitation (ChIP) Assay Service • Enzyme Activity Assay Service • DNase I Footprinting Assay Service • Protein Expression > Custom Lysate Preparation Service > C1 Expression System > Protein Co-expression Service in E. coli System > Protein Co-expression Service in Mammalian Cells • Protein Biotinylation Service • Custom Lysate Preparation Service • Immunogenicity Test Service > Anti-Drug Antibody (ADA) Evaluation Service > Neutralizing Antibody (NAb) Test Service • Anti-Drug Antibody (ADA) Evaluation Service • Neutralizing Antibody (NAb) Test Service • Thanksgiving Day Sale • C1 Expression System • Protein Conjugation Service on Beads • CLIP-Seq Service • Protein Binding Site Mapping • Quantum Dot Labeling • Protein Co-expression Service in E. coli System • Protein Co-expression Service in Mammalian Cells

CONTACT US

OUR PROMISE
Tel: 1-631-448-8149
Fax: 1-631-938-8127
Email:

Neutralizing Antibody (NAb) Test Service


A neutralizing antibody (NAb) is an antibody that defends a cell from an antigen or infectious body by neutralizing any effect it has biologically. NAbs against therapeutic proteins or peptides can significantly decrease the efficacy of these drug candidates, which is why NAb test serves as a crucial aspect in immunogenicity test.

Generally, FDA considers that bioassays are more reflective of the in vivo situation and are recommended. For NAb assays, the bioassay should be related to mechanism of action, otherwise the assays will not be informative enough as to the effect of NAbs on clinical results. The development and validation of neutralization assays are difficult and vary dramatically between different samples. Nonetheless, cell based assays are still recommended because they are critical to understanding the importance of patient immune responses to therapeutic proteins.

Cell-based NAb assay designs utilize intracellular signaling events triggered by the drug candidates or the ligand inhibited by the drug candidates, and may also utilize study of extracellular binding events at the cell surface. The frequently-used readouts for Profacgen’s NAb cell based assays include: cell proliferation, biomarker, reporter gene expression, antibody- dependent cell-mediated cytotoxicity (ADCC), etc.

The followings are provided by Profacgen for conducting a cell-based NAb assay for a given sample:

Neutralizing Antibody (NAb) Test Service

  •   Stable cell line responsive to drug
  •   Measurable readout
  •   Robust signal to noise ratio in serum matrix
  •   Availability of a positive control
  •   Medium to high throughput
  •   Adaptability to automation

Because of limitations for cell based assays (suitable cell line, interference, specificity, sensitivity, etc.), once neutralizing cell-based assays are not feasible for your sample, Profacgen can also provide competitive ligand binding assays or alternative assay methods. All these methods been verified for their reflection of neutralizing capacity/potential.

Please feel free to contact us if you are interested in or have any questions for our NAb test service.

INQUIRY

Basic
research
  Preclinical